249
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Poly(sebacic anhydride) nanocapsules as carriers: effects of preparation parameters on properties and release of doxorubicin

, , , , &
Pages 166-174 | Received 21 Feb 2014, Accepted 12 Sep 2014, Published online: 17 Oct 2014

References

  • Abdallah M, El-Etre AY. Corrosion inhibition of Nickel in sulfuric acid using tween surfactants. Portugaliae Electrochim Acta, 2003;21:315–26
  • Bagherifam S, Skjeldal FM, Griffiths G, Mælandsmo GM, Nyström B, Hasirci V, Hasirci N. pH-responsive nano carriers for doxorubicin delivery. Pharm Res, 2014. DOI: 10.1007/s11095-014-1530-0
  • Brem H, Langer R. Polymer-based drug delivery to the brain. J Sci Med, 1996;3:52–9
  • Chavanpatil MD, Khdair A, Patil Y, Handa H, Mao G, Panyam J. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs. J Pharm Sci, 2007;96:3379–89
  • Cui Z, Peng Y, Li K, Peng J, Zhao H, Turng L-S, Shen C. The degradation rate of polyanhydride (poly(sebacic acid), diacetoxy terminated, PSADT). J Wuhan Univ Technol Mater Sci Ed, 2013;28:793–7
  • Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res, 1997;14:1568–73
  • Dhanya KP, Santhi K, Dhanaraj SA, Sajeeth CI. Formulation and evaluation of chitosan nanospheres as a carrier for the targeting delivery of lamivudine to the brain. IJCP, 2011;2:1–5
  • Dong J, Frethem C, Haugstad G, Hoerr RA, Foley JD. Effect of the coating morphology on the drug release from engineered drug–polymer nanocomposites. Conf Proc IEEE Eng Med Biol Soc, 2009;2009:6006–9
  • Eke G, Kuzmina AM, Goreva AV, Shishatskaya EI, Hasirci N, Hasirci V. In vitro and transdermal penetration of PHBV micro/nanoparticles. J Mater Sci: Mater Med, 2014;25:1471–81
  • Falconi M, Focaroli S, Teti G, Salvatore V, Durante S, Nicolini B, Orienti I. Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide. J Microencapsul, 2014;31:41–8
  • Fu J, Li X, Dennis KP, Wu C. Encapsulation of phthalocyanines in biodegradable poly(sebacic anhydride) nanoparticles. Langmuir, 2002;18:3843–7
  • Fu J, Wu C. Laser light scattering study of the degradation of poly(sebacic anhydride) nanoparticles. J Polym Sci Part B Polym Phys, 2001;39:703–8
  • Guhagarkar SA, Gaikwad RV, Samad A, Malshe VC, Devarajan PV. Polyethylene sebacate–doxorubicin nanoparticles for hepatic targeting. Int J Pharm, 2010;401:113–22
  • Gunbas ID, Sezer UA, Gülce S, Deliloglu IG, Hasirci N. Semi-IPN chitosan/PEG microspheres and films for biomedical applications: Characterization and sustained release studies. Ind Eng Chem Res, 2012;51:11946–54
  • Hanes J, Chiba M, Langer R. Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. Biomaterials, 1998;19:163–72
  • Hasirci N. 2007. Micro and nano systems in biomedicine and drug delivery. In:Reza Mozafari M, ed. Nanomaterials and nanosystems for biomedical applications. Dordrecht, The Netherlands: Springer, pp. 1–26
  • Heller J, Barr J, Ng SY, Abdellauoi KS, Gurny R. Poly(ortho esters): Synthesis, characterization, properties and uses. Adv Drug Deliv Rev, 2002;54:1015–39
  • Hiremath JG, Devi VK. Paclitaxel loaded biodegradable poly (sebacic acid-co-ricinoleic acid) cylindrical implants for local delivery-in vitro characterization. Asian J Pharm, 2013;7:125–32
  • Hiremath JG, Rudani CG, Domb AJ, Suthar RV, Khamar NS. Preparation and in vitro characterization of poly(sebacic acid-co-ricinoleic acid)-based tamoxifen citrate-loaded microparticles for breast cancer. J Appl Polym Sci, 2012;124:4747–54
  • Huang M, Fong CW, Khor E, Lim LY. Transfection efficiency of chitosan vectors: Effect of polymer molecular weight and degree of deacetylation. J Control Release, 2005;106:391–406
  • Kipper MJ, Shen E, Determan A, Narasimhan B. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials, 2002;23:4405–12
  • Krasko MY, Ezra A, Domb AJ. Lithocholic-acid-containing poly(ester–anhydride)s. Polym Adv Technol, 2003;14:832–38
  • Leong KW, Brott BC, Langer R. Bioerodible polyanhydrides as drug–carrier matrices. I: Characterization, degradation, and release characteristics. J Biomed Mater Res, 1985;19(8):941–55
  • Liang Y, Xiao L, Zhai Y, Xie C, Deng L, Dong A. Preparation and characterization of biodegradable poly(sebacic anhydride) chain extended by glycol as drug carrier. J Appl Polym Sci, 2013;127:3948–53
  • Lee WC, Chu IM. Preparation and degradation behavior of polyanhydrides nanoparticles. J Biomed Mater Res B Appl Biomater, 2008;84:138–46
  • Liu J, Qiu Z, Wang S, Zhou L, Zhang S. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumour activity. Biomed Mater, 2010;5:065002
  • Mathiowitz E, Amato C, Dor P, Langer R. Polyanhydride microspheres: Morphology and characterization of systems made by solvent removal. J Polym, 1990;31:547–55
  • Muvaffak A, Gurhan I, Gunduz U, Hasirci N. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: Microsphere-antibody conjugate. J Drug Target, 2005;13(3):151–9
  • Ozerkan T, Sezer UA, Gürhan ID, Iz SG, Hasirci N. Semi-IPN chitosan/polyvinylpyrrolidone microspheres and films for biomedical applications: Sustained release and physical property optimization. J Microencapsul, 2013;30:762–70
  • Pan Y, Zheng JM, Zhao HY, Li YJ, Xu H, Wei G. Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres. Acta Pharmacol Sin, 2002;23(11):1051–6
  • Pfeifer BA, Burdick JA, Langer R. Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres. Biomaterials, 2007;26:117–24
  • Sahana B, Santra K, Basu S, Mukherjee B. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: A physicochemical and in-vitro evaluation. Int J Nanomed, 2010;5:621–30
  • Sezer UA, Aksoy EA, Hasirci V, Hasirci N. Poly(ε-caprolactone) composites containing gentamicin loaded β-TCP/gelatin microspheres as bone tissue supports. J Appl Polym Sci, 2013;127:2132–9
  • Shelke NB, Aminabhavi TM. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine. Int J Pharm, 2007;345:51–8
  • Shen E, Kipper MJ, Dziadul B, Lim MK, Narasimhan B. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. J Control Release, 2002;82:115–25
  • Shikanov A, Vaisman B, Krasko MY, Nyska A, Domb AJ. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: In vitro release and in vivo toxicity. J Biomed Mater Res A, 2004;69:47–54
  • Shoaib MH, Tazeen J, Merchant HA, Yousuf RI. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci, 2006;19:119–24
  • Tan S, Sasada T, Bershteyn A, Yang K, Ioji T, Zhang Z. Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy. Nanomedicine (Lond), 2014;9:635–47
  • Tang BC, Dawson M, Laia SK, Wang Y, Suk JS, Yang M, Zeitlin P, Boyle MP, Fu J, Hanes J. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. PNAS, 2009;106:19268–73
  • Tong R, Tang L, Yin Q, Cheng J. Drug–polyester conjugated nanoparticles for cancer drug delivery. Conf Proc IEEE Eng Med Biol Soc, 2011;2011:8337–9
  • Torchilin VP. Passive and active drug targeting: Drug delivery to tumors as an example. Handb Exp Pharmacol, 2010;197:3–53
  • Ulery BD, Phanse Y, Sinha A, Wannemuehler MJ, Narasimhan B, Bellaire BH. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres. Pharm Res, 2009;26:683–90
  • Ulubayram K, Kiziltay A, Yilmaz E, Hasirci N. Desferrioxamine release from gelatin-based systems. Biotechnol Appl Biochem, 2005;42:237–45
  • Wang XQ, Zhang Q. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Eur J Pharm Biopharm, 2012;82:219–29
  • Wong H, Bendayan R, Rauth AM, Wu XY. Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. J Pharm Sci, 2004;93:1993–2008
  • Wu C, Fu J, Zhao Y. Novel nanoparticles formed via self-assembly of poly(ethylene glycol-b-sebacic anhydride) and their degradation in water. Macromolecules, 2000;33:9040–3
  • Yang SR, Kim SB, Joe CO, Kim JD. Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation. J Biomed Mater Res A, 2008;86:137–48
  • Yilgor P, Hasirci N, Hasirci V. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A, 2010;93:528–36
  • Yilgor PH, Huri G, Umit Y, Ucar Y, Dikmen N, Hasirci N, Hasirci V. A biomimetic growth factor delivery strategy for enhanced regeneration of iliac crest defects. Biomed Mater, 2013;8(4):045009
  • Zhang J, Liang Y, Li N, Zhao X, Hu R. Poly(ether-ester anhydride)-based amphiphilic block copolymer nanoparticle as delivery devices for paclitaxel. Micro Nano Lett, 2012;7:183–7
  • Zhao T, Chen H, Dong Y, Zhang J, Huang H, Zhu J, Zhang W. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-d-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Int J Nanomed, 2013;8:1947–57
  • Zheng C, Qiu L, Yao X, Zhu K. Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: Drug encapsulation and in vitro evaluation. Int J Pharm, 2009;373:133–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.